Cerity Partners
STXS icon

Cerity Partners’s Stereotaxis STXS Stock Holding History

Cerity Partners’s Portfolio STXS Stock Details STXS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-124,011
Closed -$253K – 2586
2024
Q3 		$253K Buy
+124,011
New +$250K ﹤0.01% 2180

Other funds holding STXS

DCM
DAFNA Capital Management Los Angeles, California $440M AUM 109.12% 1-Year Est. Return
LIM
Lagoda Investment Management New York $162M AUM 49.7% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
APCM
Arbiter Partners Capital Management New York $175M AUM 99.81% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
ACM
Archon Capital Management Seattle, Washington $177M AUM 108.05% 1-Year Est. Return
EIM
Essex Investment Management Boston, Massachusetts $632M AUM 95.36% 1-Year Est. Return
PGCM
Prescott Group Capital Management Tulsa, Oklahoma $1B AUM 51.95% 1-Year Est. Return

Cerity Partners's STXS Position: Q4 2024 in Review

Cerity Partners sold out of Stereotaxis (STXS) in Q4 2024, closing a stake of 124,011 shares — an estimated $253K sold.

Cerity Partners first reported a position in STXS in Q3 2024 and held it in 1 quarter. The position peaked at $253K in Q3 2024. 86 funds tracked by Wall St. Rank hold STXS as of Q4 2024.

  • Cerity Partners reported no remaining Stereotaxis position as of Q4 2024 after selling out during the quarter.
  • Cerity Partners sold 124,011 Stereotaxis shares in Q4 2024, an estimated $253K.
  • Cerity Partners first reported a position in Stereotaxis in Q3 2024 and held it in 1 quarter.
  • Cerity Partners's Stereotaxis position peaked at $253K in Q3 2024.
  • 86 funds tracked by Wall St. Rank held Stereotaxis as of Q4 2024.

Based on Cerity Partners's 13F filing for Q4 2024, filed 13 Feb 2025.